Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma

European Journal of Haematology

Volumn 78, Issue 4, 2007, Pages 353-357

  Hayes, Michael J ^a   Carey, John L ^b   Krauss, John C ^c   Hedstrom, Deborah L ^d   Gulbranson, Ronald L ^d   Keren, David F ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c ST JOSEPH MERCY HOSPITAL   (United States)

^d Warde Medical Laboratory   (United States)

Author keywords

Bence Jones protein; Capillary zone electrophoresis; Immunofixation; Immunoglobulin E; Multiple myeloma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN E; MELPHALAN; PREDNISONE;

ADULT; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CANCER THERAPY; CASE REPORT; CLINICAL FEATURE; EMPHYSEMA; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PROTEIN ELECTROPHORESIS; EMPHYSEMA; FATAL OUTCOME; FOLLOW-UP STUDIES; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARAPROTEINEMIAS; TIME;

EID: 33847616009     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00825.x     Document Type: Article

References (17)

1. Jako JM, Gesztesi T, Kaszas I. IgE lambda monoclonal gammopathy and amyloidosis. Int Arch Allergy Immunol 1997;112:415-21.
2. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical proteins of reaginic antibody.V. Correlation of reaginic activity with gamma E globulin antibody. J Immunol 1966;97:840-53.
3. Editorial IgE immunoglobulin. Br Med J 1973;4:250-1.
4. Ogawa M, Kochwa S, Smith C, Ishizaka K, McIntyre OR. Clinical aspects of IgE myeloma. N Engl J Med 1969;281:1217-20.
5. Chusid MJ, Rock AL, Sty JR, Oechler HW, Beste DJ. Kimura's disease: an unusual cause of cervical tumour. Arch Dis Child 1997;77:153-4.
6. Johansson SGO, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 1967;13:381-94.
7. Allevato PA, Deegan MJ, Chu JW, Perry MB, Barth, CL. A case of IgE myeloma: methodology and review of the literature. Henry Ford Hosp Med J 1984;32:134-41.
8. Kairemo KJA, Lindberg M, Prytz M. IgE myeloma: a case presentation and review of the literature. Scand J Clin Lab Invest 1999;59:451-6.
9. Ludwig H, Vormittag W. "Benign" monoclonal IgE gammopathy. Br Med J 1980;23:539-40.
10. Alexander RL, Stanford TR, Petruska PJ, Tsai CC, Janney CG. A new case of IgE myeloma. Clin Chem 1992;38:2328-32.
11. Macro M, Andre I, Comby E, Cheze S, Chapon F, Ballet JJ, Reman O, Leporrier M, Troussard X. IgE multiple myeloma. Leuk Lymphoma 1999;32:597-603.
12. Vladutiu AO, Kohli RK, Prezyna AP. Monoclonal IgE with renal failure. Am J Med 1976;61:957-62.
13. Proctor SJ, Chawla SL, Bird AG, Stephenson J. Hyperviscosity syndrome in IgE myeloma. Br Med J 1984;289:1112.
14. Bemelmans RHH, van Toorn DW, van Leeuwen L, Schaar CG. Long-term complete remission in IgD-myeloma. Eur J Haematol 2006;76:339-41.
15. Grogan TM, Müller-Hermelink HK, Van Camp B, Harris NL, Kyle RA. Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman J, eds. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of Haematopoetic and Lymphoid Tissues. Lyon: IARC Press, 2000:142-56.
16. Bakshi NA, Bulbranson R, Garstka D, Bradwell AR, Keren DF. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins. Am J Clin Pathol 2005;124:214-8.
17. Durie BGM, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the scientific advisors of the International Myeloma Foundation. Hematol J 2003;4:379-98.